TOPICAL FINASTERIDE ON CLINICAL TRIAL
Thursday, July 8th, 2010Androgenic Alopecia is a popular type of hair loss in both men and women alike. Usually called as Male Pattern Baldness in male. Nevertheless, the pattern of baldness on women is very different from those of men; hair loss of women does not usually end up bald. The thinning of their hair start off all over the head and the hairline looks as if it does not retreat; thinning of hair is more likely to happen. Fortunately, a medical study introduced the most effective treatment for androgenic alopecia, called Topical Finasteride, is a much better alternative to those who does not want to take oral medicines.
The actual composition of the said medication, topical finasteride was water, propylene glycol and ethanol in the percentage of 25%, 25% and 50% in particular substance. The actual results of the said experiment were being photographed every month for easy comparison of both topical and oral finasteride treated subjects. The outcomes were purposely evaluated by sections and then weigh against those photos taken during the final part of the trial time that is on the 16th month thereafter.
Evidently, different levels acknowledge for assessment are as follows, full recovery of hair fullness, apparent bald spot diminishes, the increase of size of bald spots and also contains no result at all. Thus, the reaction of the various clinical levels of the said clinical study made no impact on the first three months of application. However, throughout the full coverage of finasteride trial, the condition of the patients pertaining to hair loss becomes remarkably progressive particularly the orally taken Finasteride medication. The feedback of the studied treatment was legitimized through the outcome of an excessive hair density on the exterior sides of the bald spots. As the finasteride probationary was in progress, the reaction of patients produced a type of hair that can readily converts to strong and stained terminal hair. Concerning to those patients treated with topical finasteride, many failed because of scarcity of positive results compare to the latter in the condition of scalp hair. However, there is a chronological ratio of the growth of the hair thickness and the terminal calculation of hair among each group. Finally, they concluded somehow that its respective difference is the same base on the trial observation of both types of finasteride. In fact, the restorative end outcome of the two experimental drugs, topical finasteride and oral finasteride proves to bear no difference with each other rather; both have similar effects after all. Furthermore, a more thorough and broader scale of topical finasteride trial will be conducted for a more credible positive outcome in the future. These facts are base on “Topical Finasteride on Clinical Trial” performed.



